In parallel to their Phase IIb trial, a global leader in pharmaceuticals was looking to pilot the same interventional study in major depressive disorder (MDD) using a decentralized clinical trial (DCT) model to evaluate operational feasibility, data quality, enrollment speed, and retention.
Science 37 helped expand reach beyond the confines of traditional sites, reaching patients who otherwise were unable to access the trial.
Science 37 delivered:
- Broad geographic coverage through our DCT model
- 21x faster recruitment in the DCT pilot study, than the brick and mortar site
- Access to both high urban/metro zip codes as well as rural
- Real-time data integration into the sponsor’s external EDC system
- And more
Download the case study to learn more.